jrnl3164

Publication Venue For

  • Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities.  470:134-140. 2020
  • The combination of BET and PARP inhibitors is synergistic in models of cholangiocarcinoma.  468:48-58. 2020
  • MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53.  459:156-167. 2019
  • Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel.  454:1-13. 2019
  • FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer.  436:75-86. 2018
  • Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c.  431:1-10. 2018
  • Retraction notice to “SRI36160 is a specific inhibitor of Wnt/<beta>-catenin signaling in human pancreatic and colorectal cancer cells” [Canc. Lett. 389C (2017) 41–48] (S030438351630800X) (10.1016/j.canlet.2016.12.030)).  422:131. 2018
  • Prostate cancer health disparities: An immuno-biological perspective.  414:153-165. 2018
  • Potential therapeutic targets of epithelial–mesenchymal transition in melanoma.  391:125-140. 2017
  • SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.  389:41-48. 2017
  • Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.  374:304-314. 2016
  • Targeting Hsp70: A possible therapy for cancer.  374:156-166. 2016
  • Aryl hydrocarbon receptor-dependent apoptotic cell death induced by the flavonoid chrysin in human colorectal cancer cells.  370:91-99. 2016
  • Targeting drivers of melanoma with synthetic small molecules and phytochemicals.  359:20-35. 2015
  • Targeted biopharmaceuticals for cancer treatment.  352:145-151. 2014
  • Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.  349:8-14. 2014
  • Epigenetic inactivation of DNA repair in breast cancer.  342:213-222. 2014
  • The mechanistic basis of arsenicosis: Pathogenesis of skin cancer.  354:211-219. 2014
  • Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the Death Receptor pathway.  348:156-166. 2014
  • Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling.  353:194-200. 2014
  • Development of an anti-angiogenic therapeutic model combining scAAV2-delivered siRNAs and noninvasive photoacoustic imaging of tumor vasculature development.  332:120-129. 2013
  • Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27KIP1 and MMP3 expression.  328:235-242. 2013
  • A novel mouse model of gastric cancer with human gastric microenvironment.  325:108-115. 2012
  • Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway.  308:181-188. 2011
  • Liver Kinase B1 (LKB1) in the pathogenesis of epithelial cancers.  306:1-9. 2011
  • Bacteriophage hyaluronidase effectively inhibits growth, migration and invasion by disrupting hyaluronan-mediated Erk1/2 activation and RhoA expression in human breast carcinoma cells.  298:238-249. 2010
  • Lifestyle as risk factor for cancer: Evidence from human studies.  293:133-143. 2010
  • Molecular mechanisms involved in farnesol-induced apoptosis.  287:123-135. 2010
  • Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.  283:29-35. 2009
  • Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells.  281:100-107. 2009
  • Targeting transforming growth factor-β signaling in liver metastasis of colon cancer.  277:114-120. 2009
  • Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.  276:32-37. 2009
  • RAP80 and RNF8, key players in the recruitment of repair proteins to DNA damage sites.  271:179-190. 2008
  • Dietary agents for chemoprevention of prostate cancer.  265:167-176. 2008
  • Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM).  258:215-222. 2007
  • Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).  235:260-265. 2006
  • Polymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population.  202:53-59. 2003
  • 9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancers.  201:17-24. 2003
  • Metastasis suppressor pathways - An evolving paradigm.  198:1-20. 2003
  • Palm oil alleviates 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion response in murine skin.  192:151-160. 2003
  • Protoporphyrin-IX accumulation and cutaneous tumor regression in mice using a ferrochelatase inhibitor.  187:9-16. 2002
  • Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats.  186:11-18. 2002
  • Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells..  183:215-220. 2002
  • Iron augments stage-I and stage-II tumor promotion in murine skin.  183:113-122. 2002
  • Green tea polyphenols and tannic acid act as potent inhibitors of phorbol ester-induced nitric oxide generation in rat hepatocytes independent of their antioxidant properties.  153:1-5. 2000
  • Evidence that ferric nitrilotriacetate mediates oxidative stress by down-regulating DT-diaphorase activity: Implications for carcinogenesis.  141:151-157. 1999
  • Potassium bromate (KBrO3) induces renal proliferative response and damage by elaborating oxidative stress.  135:181-188. 1999
  • Augmentation of 12-O-tetradecanoyl 13-phorbol acetate-mediated tumor promoting response by the porphyrin photosensitization of 7,12-dimethyl benz[a]anthracene-initiated murine skin: Role of in situ generated reactive oxygen species.  135:53-60. 1998
  • Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-α.  128:65-70. 1998
  • Effect of iron overload on the benzoyl peroxide-mediated tumor promotion in mouse skin.  126:135-142. 1998
  • KAII, a putative marker for metastatic potential in human breast cancer.  119:149-155. 1997
  • Mutations involving the endogenous ecotropic murine leukemia virus in primary mammary carcinomas of BALB/c mice.  99:121-127. 1996
  • Development of a novel human extracellular matrix for quantitation of the invasiveness of human cells.  69:123-132. 1993
  • Involvement of singlet oxygen in chloroaluminum phthalocyanine tetrasulfonate-mediated photoenhancement of lipid peroxidation in rat epidermal microsomes.  56:125-129. 1991
  • Inhibition of the skin tumorigenicity of (±)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Sencar mice.  42:7-12. 1988